You are totally misreading what I am saying. I have said that I know the purpose of the phase 1 trial is safety and not vision results but we are all hoping for some visual improvement. If we don't get it in these patients I don't see the stock moving up significantly in the near future. If we do get it, it will skyrocket. Believe me I hope we see some improvement. I have nothing to benefit from the stock going down. I have 400k shares at a cost ave of 15 cents and don't plan on buying anymore no matter how low it goes. I have plenty of shares and am just hoping the early trials are very positive. I am just guessing what these results are going to show when they release them in the near future just as everyone else is giving an opinion on how low it will go. I didn't buy this stock worrying about whether it goes down 10 cents or doubles. I bought this stock because I see the potential of it going up to $10 or $50 a share in the next 5-10 years if the science works.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.